Cocaine is the most commonly used illicit stimulant in the United States. Despite great strides in our understanding of the neuropharmacological underpinnings of cocaine addiction in the preclinical arena, the number of cocaine users in the United States has remained relatively stable in recent years, indicating that more clinical research is necessary to translate these findings to humans in an attempt to develop more effective means of reducing cocaine use. Emerging data suggest that perturbations in glutamate transmission following cocaine use (i.e., disrupted glutamate homeostasis) contribute to the maladaptive pattern of drug taking characterized by cocaine addiction. Specifically, preclinical studies indicate that cocaine exposure results in increased motivation to take cocaine and decreased drive for non-drug reinforcers. This change in reinforcer salience corresponds with complex neuropharmacological changes in the glutamate system. Whereas preclinical data suggest that targeting glutamate systems, specifically restoring glutamate homeostasis, reduces drug reinforcer salience, this research area remains relatively unexplored in humans. Some initial studies suggest that n-acetylcysteine pretreatment normalizes glutamate levels in cocaine users and that n-acetylcysteine maintenance attenuates desire for cocaine and attention to cocaine cues in abstinent cocaine-dependent subjects. Whether restoration of glutamate homeostasis impacts motivation for drug relative to non-drug reinforcers remains to be determined in humans. The research proposed here will demonstrate that restoration of glutamate homeostasis reduces motivation to take cocaine and increases motivation to obtain a non-drug alternative reinforcer (i.e., money) in cocaine-dependent humans using progressive-ratio schedules of reinforcer availability, which are an accepted means to measure motivation. The use of concurrent progressive-ratio schedules of drug and non-drug reinforcer availability will allow inferences to be made about the influence of restored glutamate homeostasis on motivation to obtain these two types of reinforcers. Cognitive tasks that assess domains relating to reinforcer choice also will be included to complement the self-administration outcomes. This study will translate findings from preclinical research and provide the initial clinical evidence tat restoration of glutamate homeostasis shifts reinforcer salience away from drug reinforcers towards non-drug reinforcers in active cocaine users. Outcomes of the experiment will not only contribute to our understanding of the clinical neuropharmacology of cocaine addiction, they also can be used to guide development of treatments for cocaine use disorders.
Preclinical data implicate disrupted glutamate homeostasis in the disordered motivation that characterizes cocaine addiction. The goal of this project is to translate preclinical findings by determining how restoration of glutamate homeostasis impacts motivation for cocaine and non-drug reinforcers in active cocaine users, which will improve our understanding of the clinical neuropharmacology of cocaine addiction and provide insights into treatment development.
| Strickland, Justin C; Marks, Katherine R; Beckmann, Joshua S et al. (2018) Contribution of cocaine-related cues to concurrent monetary choice in humans. Psychopharmacology (Berl) 235:2871-2881 |
| Levi Bolin, B; Alcorn 3rd, Joseph L; Lile, Joshua A et al. (2017) N-Acetylcysteine reduces cocaine-cue attentional bias and differentially alters cocaine self-administration based on dosing order. Drug Alcohol Depend 178:452-460 |
| Strickland, Justin C; Beckmann, Joshua S; Rush, Craig R et al. (2017) A pilot study of loss aversion for drug and non-drug commodities in cocaine users. Drug Alcohol Depend 180:223-226 |
| Alcorn 3rd, Joseph L; Pike, Erika; Stoops, William S et al. (2017) A pilot investigation of acute inhibitory control training in cocaine users. Drug Alcohol Depend 174:145-149 |
| Strickland, Justin C; Lile, Joshua A; Rush, Craig R et al. (2016) Comparing exponential and exponentiated models of drug demand in cocaine users. Exp Clin Psychopharmacol 24:447-455 |
| Czoty, Paul W; Stoops, William W; Rush, Craig R (2016) Evaluation of the ""Pipeline"" for Development of Medications for Cocaine Use Disorder: A Review of Translational Preclinical, Human Laboratory, and Clinical Trial Research. Pharmacol Rev 68:533-62 |
| Strickland, Justin C; Bolin, B Levi; Lile, Joshua A et al. (2016) Differential sensitivity to learning from positive and negative outcomes in cocaine users. Drug Alcohol Depend 166:61-8 |
| Moeller, Scott J; Stoops, William W (2015) Cocaine choice procedures in animals, humans, and treatment-seekers: Can we bridge the divide? Pharmacol Biochem Behav 138:133-41 |
| Strickland, Justin C; Wagner, Frances P; Stoops, William W et al. (2015) Profile of internet access in active cocaine users. Am J Addict 24:582-5 |
